2008-05-09 19:03:07 -

www.sjm.com - St. Jude Medical, Inc. (NYSE:STJ) announced at its annual meeting of shareholders today that Richard R. Devenuti, Stuart M. Essig, Thomas H. Garrett and Wendy Yarno were re-elected to the Company's Board of Directors for three-year terms.

In addition, shareholders approved certain amendments to the St. Jude Medical, Inc. 2007 Stock Incentive Plan and

the St. Jude Medical, Inc. 2007 Employee Stock Purchase Plan, ratified the appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm, and approved an amendment to the articles of incorporation to implement a majority voting standard for directors in uncontested elections.

About St. Jude Medical

St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical employs more than 12,000 people worldwide and has five major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation. For more information, please visit www.sjm.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings, and market shares. The statements made by the Company are based upon management's current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company's control and the risk factors and other cautionary statements described in the Company's filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company's Annual Report on Form 10-K filed on February 27, 2008. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.

St. Jude Medical
Investor Relations
Angela Craig, 651-481-7789
or
Media Relations
Kathleen Janasz, 651-415-7042